E-Cigarette Cessation Program for HispanicLatino High School Youth in Florida The BReATHE Study
Led by Florida International University · Updated on 2026-10-28
120
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to develop and test an e-cigarette cessation program specifically for HispanicLatino high school youth aged 14 to 18 who currently use e-cigarettes. The study addresses higher risks of vaping among this group and gaps in tailored treatment options. The program builds on proven cognitive behavioral therapy methods and seeks to reduce e-cigarette use by focusing on the unique needs of HispanicLatino adolescents.
Participants will take part in the BReATHE program, which includes six weekly one-hour group sessions. These sessions cover topics such as nicotine education, coping with triggers, relaxation techniques, communication skills, and a graduation activity to share learning with family. The intervention is based on cognitive behavioral therapy principles and was informed by focus groups with the target population.
During the study, participants will complete baseline assessments including questionnaires and saliva tests to measure nicotine exposure. Weekly short surveys will track e-cigarette and substance use during the intervention. A follow-up assessment occurs three months after treatment ends, including questionnaires and saliva testing. Researchers will evaluate changes in e-cigarette use, nicotine dependence, cravings, withdrawal symptoms, and related emotional and social factors over the study period.
CONDITIONS
Brief Title
Developing an E-Cigarette Cessation Intervention for Hispanic/Latina(o) Youth in Florida: The BReATHE Study
Research Team
E
Elisa Trucco, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
BReATHE Program
School‑based programs (context)
What it is
A manualized cognitive behavioral therapy (CBT) based six‑session group program tailored for Hispanic/Latina(o) high school youth using e‑cigarettes
School‑based behavioral programs that use education, coping skills, peer support, and self‑help strategies to prevent or reduce adolescent vaping
Role in the trial
Delivered as the single arm intervention being evaluated
Not part of the trial but serves as a typical context for adolescent vaping cessation efforts
Primary use
To help Hispanic/Latina(o) adolescents reduce or stop vaping through culturally informed CBT group sessions
To educate youth about vaping risks and build coping and refusal skills to discourage or stop e‑cigarette use
How it is given or performed
Delivered in six weekly 60‑minute group sessions led by trained facilitators
Typically delivered in classroom or group settings during school hours as sessions integrated into prevention curricula
Evidence status
Effectiveness not yet established; efficacy to be assessed in this trial
Mixed evidence; some programs have reduced vaping or tobacco use short‑term, but overall efficacy is low‑to‑moderate
Important risks
Risks not specified in registry; group CBT generally considered low‑risk
Not known to cause harm; some school‑based programs may inadvertently increase vaping in rare cases
Important limitations
Unproven in target population; efficacy, retention, and cultural fit still unknown
Evidence quality low‑to‑moderate; effects often short‑term and sometimes null or iatrogenic
Patient impact
Not yet established; outcomes will be assessed by e‑cigarette use and biomarker change
Short‑term improvements in knowledge, attitudes, intentions, and reduced recent tobacco use in some cases
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 14Years - 18Years
All Genders
Eligibility Criteria
You may qualify if you...
Enrolled in high school or aged 14 to 18 years
Fluent in English
Identify as Hispanic or Latino
Current e-cigarette use of at least 4 times in the past month or at least once per week in the past month
You will not qualify if you...
History of severe psychiatric conditions such as bipolar disorder, schizophrenia, psychosis, or schizoaffective disorder
Currently enrolled in or planning to join another e-cigarette or tobacco cessation program
Difficulty understanding study procedures due to language barriers, severe learning disabilities, or neurodevelopmental disorders
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Intervention
Duration - 6 weeks
Participants attend six weekly one-hour group sessions focused on nicotine education, coping strategies, communication skills, and relaxation techniques. They complete weekly surveys about vaping and substance use and provide saliva samples to measure nicotine exposure.
Weekly group sessions and surveys
Follow-up
Duration - 1 day (remote or in-person)
Participants complete a follow-up questionnaire and saliva test three months after the intervention to assess changes in e-cigarette use and nicotine exposure.
1 follow-up visit
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Study of Psilocybin vs Niacin for Smoking Cessation in Adults with Tobacco Use Disorder
Study of Accelerated Deep Transcranial Magnetic Stimulation to Help Adults Quit Smoking
A 5-Day Treatment Using Bilateral aTMS Targeting Brain Areas Linked to Tobacco Use
Study of Ear Acupressure and Nicotine Replacement Therapy to Reduce Nicotine Withdrawal and Anxiety in Psychiatric Inpatients Aged 18 to 65
QuitVaping and Texting Support Program to Help Teens Ages 14 to 19 Stop Vaping Nicotine
Study of Propranolol and Nicotine Patch Effects on Brain and Behavior in Adult Smokers
Study of Cannabidiol CBD to Help Adults Aged 18-65 Reduce Cigarette Smoking
Study of Varenicline Medication and Counseling for Adults in South Carolina to Quit Cigarettes and Reduce Cannabis Use
Mobile Contingency Management to Help Veteran Smokers Quit Around Major Elective Surgery
E-Cigarette Cessation Program for HispanicLatino High School Youth in Florida The BReATHE Study
Trial of Varenicline and Financial Incentives to Help Adults Who Use Both E-cigarettes and Cannabis Quit Vaping
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Assessing nicotine dependence in adolescent E-cigarette users: The 4-item Patient-Reported Outcomes Measurement Information System (PROMIS) Nicotine Dependence Item Bank for electronic cigarettes.
Meghan E Morean, Suchitra Krishnan-Sarin, Stephanie S O'Malley
Factors Associated With Receipt of Smoking Cessation Advice and Assistance by Health Professionals Among Latino and Non-Latino White Smokers With Medicaid Insurance in California.
Combining cognitive behavioral therapy with contingency management for smoking cessation in adolescent smokers: a preliminary comparison of two different CBT formats.